• Estudio de la fisiología de la hemostasia y sus alteraciones.
• Aterotrombosis.
• Fármacos que modifican la actividad hemostática.
• Estudio farmacogenómico de los antiagregantes plaquetarios.

• Biología molecular.
• Pruebas funcionales que exploran la actividad plaquetaria, coagulación. fibrinólisis. regulación antitrombótica de la hemostasia.

Dra. Aurora de la Peña Díaz
Profesor Titular

• (2012) Homocysteine is related to aortic mineralization in patients with ischemic heart disease.
• (2012) The structures and inhibitory effects of Buame.
• (2012) Prolame ameloriates anxiety and spatial learning and memory impairment induced by ovarectomy in rats.
• (2012) Lipoprotein (a) and homocysteine potentiate the risk of coronary artery disease in male subjects Circulation Journal.
• (2011) Aortic mineralisation in children with congenital cardiac disease.
• (2011) Mifepristone induces vasodilatation and inhibits platelet aggregation. (Falta documento)
• (2011) Angiotensina
• (2011) Prasugrel resistance may be linked to the sticky platelet síndrome.
• (2011) The effect of vanadium on platelet function. Enviromental Toxicology and Pharmacology. ( Falta documento)
• (2010) The antithrombotic effect of the aminoestrogen prolame.
• (2010) Apo(a) phenotyping and long-term prognosis for coronary artery disease.
• Distribution of ABCB1, CYP3A5, CYP2C19 and P2RY12 gene polymorphisms in a Mexican Mestizos population.